Skip to Content MayoACCESS MayoLINK...
Dementia with Lewy bodies, Parkinson's, and multiple system atrophy - Insights
Learn more about how Mayo Clinic Laboratories' cerebrospinal fluid biomarker test for synucleinopathies, such as Parkinson’s disease and dementia with Lewy bodies, can accurately identify α-syn pathology even before definitive symptoms...
Find out how our pediatric oncology testing was designed to deliver individualized insights to confirm diagnosis and guide treatment.
Cytogenetic Testing for Pediatric Patients With Hematologic Malignancies - Insights
In this month's "Hot Topic," Patricia Greipp, D.O., discusses fluorescence in situ hybridization, or FISH testing, particularly related to pediatric patients with hematologic malignancies.
Raising the Bar on Newborn Screening Test Performance - Insights
Newborn screening panels that test for a variety of conditions are available in every state; however, test performance and response rate by each state are very different. Mayo Clinic's Biochemical Genetics Laboratory created the...
Cardiovascular Biomarkers of Atherosclerotic Risk - Insights
In this month’s “Hot Topic,” Vlad Vasile, M.D., Ph.D., reviews ceramides and their atherosclerotic risk through defining ceramides, talking about when they should be tested for and touch on the topic of ceramides in primary prevention.
Addiction rehabilitation monitoring - Insights
Encompassing comprehensive profiles, confirmatory testing, and interpretive results reporting, addiction rehabilitation monitoring at Mayo Clinic Laboratories supports patients affected by substance use disorder in their rehabilitation and...
Lab medicine is an ever-evolving field, and staying up to date can be a challenge. Mayo Clinic Laboratories' podcasts are designed to share the information you need to know about the latest developments in laboratory diagnostics.
Specimen Collection and Preparation - Mayo Clinic Laboratories
Share Print Web: mayocliniclabs.com...
Week in Review: May 27 - Insights
Today's highlights include: Long COVID affects more older adults, US has a new dominant COVID-19 strain, and Gianrico Farrugia explains how we can transform healthcare by moving from pipeline to platform.